Florida has begun sending surveys to hospitals to determine if they're able to store vaccines that need to be kept at ultra-low temperatures and plans to send the surveys to pharmacies as well, WFTV, an ABC affiliate in Orlando, reported.
Pharmacy
Jason Kilvinger, who owned New Berlin (Wis.) Pharmacy, pleaded no contest to six felony counts accusing him of illegal drug distribution and insurance and identity fraud, according to a Nov. 10 report from Milwaukee Journal Sentinel.
There are a few pieces of good news that can be derived from Pfizer's Nov. 9 announcement that interim analysis of its COVID-19 vaccine trial revealed the candidate can prevent more than 90 percent of infections, healthcare officials say.
A drug being developed by AstraZeneca and Amgen significantly reduced the frequency of asthma attacks in patients with severe asthma, the drugmakers said Nov. 10.
Ibuprofen may be more effective at treating pain and fever in infants, according to a review of 19 studies involving hundreds of thousands of infants published JAMA Network Open.
HHS will begin distributing Eli Lilly's COVID-19 antibody drug this week, though initial supplies will be limited, The Hill reported.
An AbbVie unit has filed a lawsuit against Takeda, alleging it failed to supply AbbVie with enough of the drug Lupron to fulfill a deal the two drugmakers made, Bloomberg reported.
The FDA is requiring the teams who run clinical trials for new treatments and medical products to ensure greater enrollment for underrepresented groups so that the resulting products do not exacerbate existing health disparities, the agency said in final guidance…
Six in 10 Americans said they would receive a COVID-19 vaccine if it lowers the risk of being infected by half, according to the latest iteration of STAT and The Harris Poll's COVID-19 vaccination survey.
The FDA has fast-tracked Novavax's COVID-19 vaccine, which is currently in late-stage development, the drugmaker said Nov. 9.